简体
简体中文
繁體中文

Simplify增强型收益主动型ETF HIGH 深 沪

等待开盘 11-19 09:30:00 美东时间

20.41

0.000

0.00%

华盛通华盛通
立即下载
  • 最 高20.48
  • 今 开20.28
  • 成交量 1.73万股
  • 最 低 20.28
  • 昨 收 20.41
  • 总市值 5306.60万
  • 52周最高 22.4499
  • 市盈率 静 --
  • 换手率 0.67%
  • 52周最低 20.09
  • 委 比 0.00%
  • 总股本 260.00万
  • 历史最高 23.0441
  • 量 比 1.90
  • 振 幅 0.98%
  • 历史最低 17.3672
  • 每 手 1
  • 风险率 0.28%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Gary Hill Bought 8.1% More Shares In Team

    Whilst it may not be a huge deal, we thought it was good to see that the Team, Inc. ( NYSE:TISI ) Chief Executive...

    29分钟前

  • Sudhir Srivastava Buys Handful Of Shares In SS Innovations International

    Investors who take an interest in SS Innovations International, Inc. ( NASDAQ:SSII ) should definitely note that the...

    48分钟前

  • Insider Traders Lose US$173k As Beyond Air Drops

    Insiders who acquired US$287.3k worth of Beyond Air, Inc.'s ( NASDAQ:XAIR ) stock at an average price of US$4.63 in the...

    53分钟前

  • Gary Roubin Spends US$100k Buying InspireMD Shares

    Whilst it may not be a huge deal, we thought it was good to see that Gary Roubin, who is a company insider, recently...

    今天 19:15

  • This Insider Has Just Sold Shares In JFrog

    Some JFrog Ltd. ( NASDAQ:FROG ) shareholders may be a little concerned to see that the Co-Founder & Director, Frederic...

    今天 18:26

  • Trade Alert: Independent Director Of Ardmore Shipping Kirsi Kyllikki Tikka Has Sold Stock

    We'd be surprised if Ardmore Shipping Corporation ( NYSE:ASC ) shareholders haven't noticed that the Independent...

    今天 18:09

  • Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

    Neumora Therapeutics submitted an IND for NMRA-215 (NLRP3 inhibitor) for obesity and cardiometabolic disease. NMRA-511 (V1aR antagonist) showed dose-proportional exposure in a MAD expansion cohort, suggesting potential to build on Phase 1b efficacy in AD agitation. The company reported a cash position of $85.7 million as of September 30, 2026, with R&D expenses at $22.6 million and a net loss of $34.4 million for the quarter. NMRA-215 demonstrate...

    11-16 13:00

  • Solaris Receives Final US$50 Million Tranche Under Royal Gold Funding Package

    Solaris Resources Inc. has received the final $50 million tranche under its $200 million non-dilutive funding package with Royal Gold, completing the three scheduled instalments. The Company now has $54 million in cash and equivalents, with the additional $50 million strengthening its financial position. This funding supports advancing the Warintza project toward full permits. CEO Matthew Rowlinson expressed gratitude to Royal Gold for their part...

    11-09 12:00

  • Strawberry Fields Reit Announces Third Quarter 2026 Operating Results

    Strawberry Fields REIT reported Q3 2026 operating results, highlighting 100% collection of contractual rents and two property acquisitions totaling $25.4 million. FFO was $(3.6) million for the quarter, down from $20.7 million in Q3 2025, while AFFO rose to $18.8 million from $18.1 million. Year-to-date FFO was $37.6 million, down from $58.9 million in 2025, with AFFO at $55.9 million versus $53.4 million. The company attributes the decline in ne...

    11-05 22:00

  • LETTER TO SHAREHOLDERS

    Devon Energy has achieved significant milestones since its Coterra combination, including a comprehensive portfolio review, strategic divestitures, and major acquisitions in the Permian Basin. The company emphasizes operational excellence, technology innovation, and a disciplined approach to capital allocation. Key initiatives include expanding in the Permian Basin, optimizing complementary assets, and enhancing shareholder returns through increa...

    11-05 21:11